CDT
NASDAQConduit Pharmaceuticals
$4.08
-1.81 (-30.73%)
Institutional
0.0%
Insider
1.49%
Retail/Other
98.5%
Shares Outstanding
4.7M
Institutional Holders
No institutional holder data available.
Insider Transactions
Last 24 months (2 insiders)
Andrew Regan / Corvus Capital Ltd.
Chief Executive Officer/ 10% Owner
227,304 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 224,800 | $1.79 | $402,392 | 2025-12-08 | 227,304 |
Chele Chiavacci Farley
Director
17,157 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 10,553 | $1.04 | $10,975 | 2026-02-19 | 17,157 |
Congressional Trading
STOCK Act DisclosuresNo congressional trading data available for this ticker.
Congressional trading data is sourced from STOCK Act disclosures and may not be available for all tickers.
Based on public disclosures. Reporting errors by representatives are common. Disclosure deadlines are 45 days after transaction.